Superior Intellect was founded as the consulting arm of a sister company back in late November of 1994. We are a privately owned company focused on the ECM industry and expertly paired technology solutions for varied business sectors of the North and South American countries. We also extend some expertise and solution work for other countries around the world.
Our upper management and company ownership also encourage employees to make good investments for their own personal futures and to provide analysis with technologies in all sorts of vertical industries to pinpoint new markets for our consulting services. One of these verticals is the BioPharma vertical for new therapeutics and new drug development in the USA.
It was here our company and two internal investing employees discovered Enzolytics, Inc. The original company named in the lawsuit we’re now helping organize and execute as a court case. It’s also how we continued with the discovery of the actual defrauding of investors that occurred, and all four of the main principles whom all share equal liability for past Enzolytics operations that defrauded investors to the tune of a 9-figures in shareholder investments.
These 4 principals now reside in two different companies. One with new sub-partners at Enzolytics, the original company where all 4 undertook business operations, and defrauding practices and two, Adnexus Biotech, where 3 of the principals escaped the downfall of Enzolytics, and took 3 vital IP’s with them to reopen shop and operations at Adnexus Biotech, Dr. Gaurav Chandra, principal owner and CEO at the time this legal action was initiated.
So for the time being, we’re dedicating our skills and efforts to assisting with the prosecution of the fraud case against all 4 principals, especially those at Adnexus Biotech, since the principal at Enzolytics is already under multiple charges of fraud brought forth by the SEC for illegal stock sales, financial malfeasance, intentionally misleading public announcements and other communications, and other forms of fraud that denoted in that case action now underway in Q4 of 2024.
It is our case petition that the 3 principals of the ‘CCC Group’, our anacronym for them, now at Adnexus Biotech and comprised of attorney and former CEO, Charles Cotropia, Research Leader Dr. Joseph Cotropia and CTO, Dr. Gaurav Chandra, intentionally did not alert shareholders of known business and shareholder relationship violations when and as they occurred at Enzolytics. We furthermore stand ready to prove they closed down one shop at Enzolytics, and reopened the same operations shop based on the same Intellectual Properties at their new location of Adnexus Biotech.
Regardless of their reasons, the CCC group participated in covering up the truth to a great degree. They also made false promises and claims, with full knowledge the shareholders would be damaged far more than they ever would, as they attempt to reopen shop at Adnexus Biotech and shun their responsibility for fraudulent actions taken while still at Enzolytics.
We also will be pursuing court-approved forensic investigations for potentially adding more charges should other suspicions of The shareholders prove to be true.
This is the current and primary intent of Superior Intellect.com.